Particle.news

Aspen Aerogels Maps 2026 Recovery With Cost Cuts, Europe Pivot and Strategic Review

Management guides to a Q1 revenue trough before a sequential rebound.

Overview

  • - Q4 results were pressured by a sharp drop in U.S. EV demand and GM’s production ramp‑down, with gross margins hurt by lower absorption, a $3 million bad‑debt charge and year‑end adjustments.
  • - The company implemented about $75 million in annual fixed‑cost reductions, amended its MidCap credit agreement for added covenant flexibility and emphasized a strengthened liquidity position.
  • - Guidance calls for sequential growth after Q1 2026 as GM output normalizes and European OEM programs ramp, with adjusted‑EBITDA breakeven targeted to fall to roughly $175 million by 2027.
  • - Strategy is shifting toward Europe, where EV penetration exceeds 20%, with multiple OEM design wins including Volvo and an expected 2026 revenue contribution of $10–$15 million that management projects could scale substantially by 2028.
  • - Diversification efforts include building a BESS business and leaning on an Energy Industrial rebound, where management expects roughly 20% growth in 2026 supported by a renewed subsea pipeline, expanding LNG work and a North Sea pipe‑in‑pipe award slated for Q3 delivery.